Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia-Reference-Cited by-同舟云学术

Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia

Published:2008-08 Issue:2 Volume:87 Page:133-145
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Morgan Steve,McMahon Meghan,Greyson Devon

Publisher

Elsevier BV

Subject

Health Policy

Reference50 articles.

1. Health policy versus industrial policy in the pharmaceutical sector: the case of Canada;Vandergrift;Health Policy,1997

2. Money or your life? The health–wealth trade-off in pharmaceutical regulation;Maynard;Journal of Health Services and Policy Research,2001

3. Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality,2004

4. Centralized drug review processes in Australia, Canada, New Zealand and the United Kingdom;Morgan;Health Affairs,2006

5. Jacobzone S. Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals. Occasional Papers, No. 40. OECD Directorate for Education, Employment, Labour and Social Affairs. http://www.olis.oecd.org/OLIS/2000DOC.NSF/LINKTO/DEELSA-ELSA-WD(2000)1; 2000.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Local Pharmaceutical Manufacturing Sector in a Low-income Country: A Descriptive Study;2024-09-11

2. Lessons from the crisis (On the book “The response of Russian business to the COVID-19 pandemic (Six industry cases)” edited by T. G. Dolgopyatova, N. V. Akindinova, Y. V. Simachev, A. A. Yakovlev);Voprosy Ekonomiki;2022-06-08

3. Reimagining Health as a ‘Flow on Effect’ of Biomedical Innovation: Research Policy as a Site of State Activism;Minerva;2022-01-18

4. Reaction of Small and Medium-Sized Enterprises to the Corona Crisis: the Impact of Regional Authorities;Economy of Region;2022

5. Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science;Journal of Pharmaceutical Policy and Practice;2019-06-27